Utilizing mouse models of human cancer for assessing immune modulation of cancer development

Karin E. de Visser, Lisa Coussens

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The availability and diversity of mouse models of human cancer that develop organ-specific neoplasms has increased significantly in the past 10 years. These, coupled with mouse strains where components of the immune system have been manipulated or deleted, have provided novel insights into how immune cells and immune function significantly contributes to cancer development. Herein, we review relevant literature, where mouse models of human cancer development have provided novel insights into mechanisms of pro- versus antitumor immunity.

Original languageEnglish (US)
Title of host publicationGenetically Engineered Mice for Cancer Research: Design, Analysis, Pathways, Validation and Pre-Clinical Testing
PublisherSpringer New York
Pages443-463
Number of pages21
ISBN (Print)9780387698052, 9780387698038
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Neoplasms
Human Development
Immune System
Immunity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

de Visser, K. E., & Coussens, L. (2012). Utilizing mouse models of human cancer for assessing immune modulation of cancer development. In Genetically Engineered Mice for Cancer Research: Design, Analysis, Pathways, Validation and Pre-Clinical Testing (pp. 443-463). Springer New York. https://doi.org/10.1007/978-0-387-69805-2_21

Utilizing mouse models of human cancer for assessing immune modulation of cancer development. / de Visser, Karin E.; Coussens, Lisa.

Genetically Engineered Mice for Cancer Research: Design, Analysis, Pathways, Validation and Pre-Clinical Testing. Springer New York, 2012. p. 443-463.

Research output: Chapter in Book/Report/Conference proceedingChapter

de Visser, KE & Coussens, L 2012, Utilizing mouse models of human cancer for assessing immune modulation of cancer development. in Genetically Engineered Mice for Cancer Research: Design, Analysis, Pathways, Validation and Pre-Clinical Testing. Springer New York, pp. 443-463. https://doi.org/10.1007/978-0-387-69805-2_21
de Visser KE, Coussens L. Utilizing mouse models of human cancer for assessing immune modulation of cancer development. In Genetically Engineered Mice for Cancer Research: Design, Analysis, Pathways, Validation and Pre-Clinical Testing. Springer New York. 2012. p. 443-463 https://doi.org/10.1007/978-0-387-69805-2_21
de Visser, Karin E. ; Coussens, Lisa. / Utilizing mouse models of human cancer for assessing immune modulation of cancer development. Genetically Engineered Mice for Cancer Research: Design, Analysis, Pathways, Validation and Pre-Clinical Testing. Springer New York, 2012. pp. 443-463
@inbook{4938c22a97b74029be155404901e220b,
title = "Utilizing mouse models of human cancer for assessing immune modulation of cancer development",
abstract = "The availability and diversity of mouse models of human cancer that develop organ-specific neoplasms has increased significantly in the past 10 years. These, coupled with mouse strains where components of the immune system have been manipulated or deleted, have provided novel insights into how immune cells and immune function significantly contributes to cancer development. Herein, we review relevant literature, where mouse models of human cancer development have provided novel insights into mechanisms of pro- versus antitumor immunity.",
author = "{de Visser}, {Karin E.} and Lisa Coussens",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-0-387-69805-2_21",
language = "English (US)",
isbn = "9780387698052",
pages = "443--463",
booktitle = "Genetically Engineered Mice for Cancer Research: Design, Analysis, Pathways, Validation and Pre-Clinical Testing",
publisher = "Springer New York",

}

TY - CHAP

T1 - Utilizing mouse models of human cancer for assessing immune modulation of cancer development

AU - de Visser, Karin E.

AU - Coussens, Lisa

PY - 2012/1/1

Y1 - 2012/1/1

N2 - The availability and diversity of mouse models of human cancer that develop organ-specific neoplasms has increased significantly in the past 10 years. These, coupled with mouse strains where components of the immune system have been manipulated or deleted, have provided novel insights into how immune cells and immune function significantly contributes to cancer development. Herein, we review relevant literature, where mouse models of human cancer development have provided novel insights into mechanisms of pro- versus antitumor immunity.

AB - The availability and diversity of mouse models of human cancer that develop organ-specific neoplasms has increased significantly in the past 10 years. These, coupled with mouse strains where components of the immune system have been manipulated or deleted, have provided novel insights into how immune cells and immune function significantly contributes to cancer development. Herein, we review relevant literature, where mouse models of human cancer development have provided novel insights into mechanisms of pro- versus antitumor immunity.

UR - http://www.scopus.com/inward/record.url?scp=84942798129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942798129&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-69805-2_21

DO - 10.1007/978-0-387-69805-2_21

M3 - Chapter

SN - 9780387698052

SN - 9780387698038

SP - 443

EP - 463

BT - Genetically Engineered Mice for Cancer Research: Design, Analysis, Pathways, Validation and Pre-Clinical Testing

PB - Springer New York

ER -